L'Oréal Group | Research
L’ORÉAL GROUPE PARTNERS WITH ABOLIS AND EVONIK TO SCALE DEVELOPMENT OF NEXT-GENERATION BIO-BASED INGREDIENTS
Clichy, September 12, 2024 - L’Oréal today announces a tri-party agreement with biotech innovator, Abolis Biotechnologies and global specialty manufacturer, Evonik, to enable the discovery, development and manufacturing of innovative and sustainable ingredients for beauty products and beyond.